Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,500,000
Closed -$16.7M 36
2023
Q1
$16.7M Sell
1,500,000
-42,500
-3% -$411K 0.41% 25
2022
Q4
$15.3M Sell
1,542,500
-5,739,175
-79% -$51.7M 0.42% 23
2022
Q3
$87M Sell
7,281,675
-2,100,000
-22% -$45.2M 2.57% 14
2022
Q2
$298M Sell
9,381,675
-200,600
-2% -$5.16M 7.46% 5
2022
Q1
$264M Buy
9,582,275
+800,000
+9% +$28.4M 10.45% 3
2021
Q4
$442M Buy
8,782,275
+700,000
+9% +$31.6M 13.52% 1
2021
Q3
$287M Buy
8,082,275
+82,275
+1% +$3.27M 9.57% 3
2021
Q2
$355M Sell
8,000,000
-3,629,425
-31% -$124M 11.64% 3
2021
Q1
$425M Buy
11,629,425
+1,250,000
+12% +$52M 16.81% 1
2020
Q4
$445M Hold
10,379,425
17.54% 1
2020
Q3
$208M Buy
+10,379,425
New +$203M 13.37% 2

Other funds holding XPEV

Aspex Management (HK)'s XPEV Position: Q2 2023 in Review

Aspex Management (HK) sold out of XPeng (XPEV) in Q2 2023, closing a stake of 1,500,000 shares — an estimated $16.7M sold.

Aspex Management (HK) first reported a position in XPEV in Q3 2020 and held it in 11 quarters. The position peaked at $445M in Q4 2020. 201 funds tracked by Wall St. Rank hold XPEV as of Q2 2023.

  • Aspex Management (HK) reported no remaining XPeng position as of Q2 2023 after selling out during the quarter.
  • Aspex Management (HK) sold 1,500,000 XPeng shares in Q2 2023, an estimated $16.7M.
  • Aspex Management (HK) first reported a position in XPeng in Q3 2020 and held it in 11 quarters.
  • Aspex Management (HK)'s XPeng position peaked at $445M in Q4 2020.
  • 201 funds tracked by Wall St. Rank held XPeng as of Q2 2023.

Based on Aspex Management (HK)'s 13F filing for Q2 2023, filed 14 Aug 2023.